PRÁTICAS CLÍNICAS APLICADAS A PACIENTES COM INFARTO DO MIOCÁRDIO SEM OBSTRUÇÃO DE ARTÉRIA CORONÁRIA (MINOCA)
DOI:
https://doi.org/10.36489/nursing.2023v26i300p9616-9624Palavras-chave:
Infarto do miocárdio sem obstrução de artéria coronária, Terapêuticas, Tratamento, Tomada de decisão clínicaResumo
Objetivo: Identificar práticas clínicas com resultados favoráveis aos pacientes com diagnóstico de infarto agudo do miocárdio sem obstrução de artéria coronária. Método: Revisão integrativa da literatura pela base de dados National Library of Medicine e Biblioteca Virtual de Saúde. Resultados: 87,5% dos estudos encontrados destacaram estratégias farmacológicas e destes, 62,5% citaram o uso da dupla antiagregação plaquetária como mais utilizada, apesar de nenhum estudo evidenciar benefícios. Os inibidores do sistema renina-angiotensina-aldosterona comprovaram benefícios em três estudos. 75% dos artigos apontaram que esse grupo de pacientes recebem menos medicamentos preventivos comparados aos pacientes com infarto por obstrução coronariana. Outros seis estudos, revelaram condução clínica variável desses pacientes. Conclusão: O uso de inibidores do sistema renina-angiotensina-aldosterona deve ser considerado por ser a única medicação com redução da mortalidade evidenciada. São necessários estudos maiores para orientar com mais segurança à condução do infarto do miocárdio sem obstrução de coronária.
Referências
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal DefinitionofMyocardialInfarction. J Am Coll Cardiol[Internet]. 2018 [cited 2022 Jun 25]; 72(18):2231-2264. Availablefrom: https://pubmed.ncbi.nlm.nih.gov/30153967
Lindahl B, Baron T, Albertucci M, Prati F. Myocardialinfarctionwith non-obstructivecoronaryarterydisease. EuroIntervention [internet]. 2021 [cited 2022 Jun 25]; 17:e875-e887. Availablefrom: https://eurointervention.pcronline.com/article/myocardial-infarction-with-non-obstructive-coronary-artery-disease
Matta AG, Nader V, Roncalli J. Management ofmyocardialinfarctionwithNonobstructiveCoronaryArteries (MINOCA): a subsetofacutecoronarysyndromepatients. Rev.Cardiovasc. [internet]. 2021 [cited 2022 Jun 25]; 22(3), 625–634; Availablefrom: https://www.imrpress.com/journal/RCM/22/3/10.31083/j.rcm2203073/htm
Asamoah K T. MyocardialInfarctionwithNonobstructiveCoronaryArteries: A DiagnosticChallenge. TH Open. [internet]. 2021 [cited 2022 Jun 25]; e195–e199; Availablefrom: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208841
Shamsi F, Hasan KY, Hashmani S, Jamal SF, Ellaham S. ReviewArticle—Clinical Overview ofMyocardialInfarctionWithoutObstructiveCoronaryArteryDisease (MINOCA). J Saudi Heart Assoc. [internet]. 2021 [cited 2022 Jun 25]; 33(1): 9–15. Availablefrom: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051331
Hjort M, Lindahl B, Baron T, Jernberg T, Tornvall P, Eggers KM. Prognosis in relationto high-sensitivitycardiactroponin T levels in patientswithmyocardialinfarctionand non-obstructivecoronaryarteries. Am Heart J. [internet]. 2018 [cited 2022 Jun 25]. 200:60-66; Availablefrom: https://pubmed.ncbi.nlm.nih.gov/29898850/
Pelliccia F, Pasceri V, Niccoli G, Gaudio C, Crea F, Camici PG. PredictorsofMortality in MyocardialInfarctionandNonobstructedCoronaryArteries: A SystematicReviewand Meta-Regression. Am J Med. [internet]. 2019 [cited 2022 Jun 25]; 2019.05.048; Availablefrom: https://www.amjmed.com/article/S0002-9343(19)30530-3/fulltext
Eggers KM, Hjort M, Baron T, Jernberg T, Nordenskjöld AM, Tornvall P, et al. Morbidityand cause-specificmortality in first-time myocardialinfarctionwithnonobstructivecoronaryarteries. Jo I. M. [internet]. 2018 [cited 2022 Jun 25]; 12857; Availablefrom: https://onlinelibrary.wiley.com/doi/10.1111/joim.12857
Abdu FA, Mohammed AQ, Liu L, Xu Y, Che W. MyocardialInfarctionwithNonobstructiveCoronaryArteries (MINOCA): A ReviewoftheCurrent Position. Karger. [internet]. 2020 [cited 2022 Jun 25]; 145:543–552; Availablefrom: https://www.karger.com/Article/Pdf/509100
Serpytis R, Majauskiene E, Navickas P, Lizaitis M, Glaveckaite D, Rucinskas K, et al. RandomizedPilotTrialonOptimalTreatmentStrategy, MyocardialChanges, andPrognosisofPatientswithMyocardialInfardtionwithNonobstructiveCoronaryArteries (MINOCA). Am J Med. [internet]. 2021. [cited 2022 Jun 25]; 2021.08.023; Availablefrom: https://www.sciencedirect.com/science/article/abs/pii/S0002934321005866#preview-section-cited-by
Souza MT, Silva MD, Carvalho R, Revisão integrativa: o que é e como fazer. Einstein. [internet]. 2010. [cited 2022 Jun 18]. Availablefrom: https://www.scielo.br/j/eins/a/ZQTBkVJZqcWrTT34cXLjtBx/?lang=pt
Santos CM, Pimenta CA, Nobre MR. A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Rev. Latino-Am. Enfermagem. [Internet]. 2007. [cited 2022 Jun 18]. Availablefrom: https://www.scielo.br/j/rlae/a/CfKNnz8mvSqVjZ37Z77pFsy/?lang=pt
Qualis/CAPES. Plataforma Sucupira. Disponível em: https://sucupira.capes.gov.br/sucupira/public/index.xhtml
Safdar B, Spatz ES, Dreyer RP, Beltrame JF, Lichtman JH, Spertus JÁ, et al. Presentation, Clinical Profile, andPrognosisof Young PatientsWithMyocardialInfarctionWithNonobstructiveCoronaryArteries (MINOCA): ResultsFromthe VIRGO Study. J Am Heart Assoc. [Internet]. 2018 [cited 2022 Nov 11]; 7(13): e009174; Availablefrom: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064896
Paliosso P, Bergamaschi L, Saturi G, D´Angelo, EC, Magnani I, Toniolo S, et al. SecondaryPrevention Medical TherapyandOutcomes in PatientsWithMyocardialInfarctionWith Non-ObstructiveCoronaryArteryDisease. Front Pharmacol. [Internet] 2020. [cited 2022 Nov 23]; 10: 1606; Availablefrom: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005107
Gasior P, Desperak A, Gierlotka M, Milewski K, Wita K, Kalarus Z, et al. ClinicalCharacteristics, Treatments, andOutcomesofpatientsqithMyocardialInfarctionwith Non-ObstructivecoronaryArteries (MINOCA): Resultsfrom a MulticenterNational Registry. J. Clin Med. [Internet]. 2020 [cited 2022 Nov 23]; 9(9):2779; Availablefrom: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564426
Sá F M, Carvalho RC, Santos L, Ruivo C, Antunes A, Belo A, et al. Dual antiplatelettherapy in myocardialinfarctionwith non-obstructivecoronaryarterydisease – insights from a nationwide registry. J.Rev.P.C. [Internet]. 2020 [cited 2022 Nov 23]. 2020.05.008; Availablefrom: https://www.sciencedirect.com/science/article/pii/S087025512030408X?via%3Dihub
Reynolds HR, Maehara A, Kwong RY, Sedlak T, Saw J, Smilowitz NR, et al. CoronaryOpticalCoherenceTomographyandCardiacMagneticResonanceImagingto Determine Underlying Causes ofMyocardialInfarctionWithNonobstructiveCoronaryArteries in Women. Circulation AHA. [Internet]. 2021 [cited 2022 Nov 23]; 143(7): 624–640.Availablefrom: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627695
Ahn JH, Hyun JY, Jeong MH, Kim JH, Hong YJ, Sim DS, et al. Comparativeeffectofangiotensinconvertingenzymeinhibitor versus angiotensin II type I receptor blocker in acutemyocardialinfarctionwith non-obstructivecoronaryarteries; fromtheKoreaAcuteMyocardialInfarction Registry—NationalInstituteof Health. Cardiol J. [Internet]. 2021 [cited 2022 Nov 23]; 28(5): 738–745 Availablefrom: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428933
Gao S, Xu H, Huang S, Yuan J, Yu M. Real-World Use ofClopidogrelandTicagrelor in PatientsWithMyocardialInfarctionWithNonobstructiveCoronaryArteries: PatientCharacteristicsandLong-TermOutcomes. Front Cardiovasc. Med. [Internet]. 2021 [cited 2022 Nov 23]. 8: 807494 Availablefrom: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724121
Smilowitz NR, Dubner R, Hellkamp AS, Widmer RJ, Reynolds HR. Variabilityofdischarge medical therapy for secondarypreventionamongpatientswithmyocardialinfarctionwith non-obstructivecoronaryarteries (MINOCA) in the United States. Journal P One. [Internet]. 2021 [cited 2022 Nov 23]; e0255462 Availablefrom: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328325
Amores N, Salvador P. Utilidaddelultrasonidointracoronarioenel diagnóstico de diseccióncoronaria espontânea. Arch. Cardiol. Méx. [Internet]. 2019 [cited 2022 Nov 23]. 19000013; Availablefrom: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1405-99402019000100082
